Encompass Health Purchases Land in St. Augustine, Florida

Announces Plans for Future Inpatient Rehabilitation Hospital

July 10, 2020

Encompass Health Corp. announced it has purchased land located at the northwest corner of Silver Lane and Highway 207 in St. Augustine, Florida for the future development of a 40-bed inpatient rehabilitation hospital to serve patients recovering from debilitating illnesses and injuries.

Encompass Health notes the planned hospital, once opened, will become part of Encompass Health’s national network of inpatient rehabilitation hospitals and home health and hospice agencies. The Company’s Florida footprint currently includes 12 inpatient rehabilitation hospitals, a hospital under construction in north Tampa, a planned hospital in Pensacola and 19 home health locations. A construction timeline for the hospital has not yet been established.

“This new, state-of-the-art hospital will help meet a growing need for intensive physical rehabilitative services in the St. Augustine area,” said Linda Wilder, president of Encompass Health’s southeast region. “Provided in a hospital setting, Encompass Health’s services are tailored to meet each patient’s complex needs and help them regain the strength and confidence they need to return to their community at their highest level of independence.”

Services at Encompass Health inpatient rehabilitation hospitals complement those provided by local acute care hospitals. Offering 24-hour nursing care, physical, occupational and speech therapies, and a multi–specialty medical staff, the hospitals treat patients recovering from strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version